The Coincidence Between Increasing Age, Immunosuppression, and the Incidence of Patients With Glioblastoma

Background: Glioblastoma (GBM) is the most aggressive primary brain tumor in adults and is associated with a median overall survival (mOS) of 16–21 months. Our previous work found a negative association between advanced aging and the survival benefit after treatment with immunotherapy in an experime...

Descripción completa

Detalles Bibliográficos
Autores principales: Ladomersky, Erik, Scholtens, Denise M., Kocherginsky, Masha, Hibler, Elizabeth A., Bartom, Elizabeth T., Otto-Meyer, Sebastian, Zhai, Lijie, Lauing, Kristen L., Choi, Jaehyuk, Sosman, Jeffrey A., Wu, Jennifer D., Zhang, Bin, Lukas, Rimas V., Wainwright, Derek A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446059/
https://www.ncbi.nlm.nih.gov/pubmed/30971917
http://dx.doi.org/10.3389/fphar.2019.00200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446059/
https://www.ncbi.nlm.nih.gov/pubmed/30971917
http://dx.doi.org/10.3389/fphar.2019.00200

Ejemplares similares